(Q36972613)

English

Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients

scientific article published on 31 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

0 references

1 reference

based on heuristic

inferred from title

Paolo Antonio Ascierto

6

object named as

Paolo Antonio Ascierto

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

5

object named as

Ester Simeone

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

author name string

Laura Ridolfi

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Massimiliano Petrini

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Anna Maria Granato

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Giusy Gentilcore

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Elena Pancisi

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Valentina Ancarani

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Laura Fiammenghi

9

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Massimo Guidoboni

10

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Francesco de Rosa

11

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Linda Valmorri

12

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Emanuela Scarpi

13

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Stefania Vittoria Luisa Nicoletti

14

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Stefano Baravelli

15

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Angela Riccobon

16

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Ruggero Ridolfi

17

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

publication date

31 May 2013

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Journal of Translational Medicine

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

135

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

29 September 2017

Molecular profiling of melanoma and the evolution of patient-specific therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

29 September 2017

Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

29 September 2017

Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

29 September 2017

Regulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-alpha 2b treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

29 September 2017

Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

29 September 2017

Immunotherapy for melanoma: current status and perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

29 September 2017

Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

29 September 2017

Dendritic cells: understanding immunogenicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

29 September 2017

Temozolomide for the treatment of metastatic melanoma: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

29 September 2017

Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

29 September 2017

Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

29 September 2017

Alternating chemo-immunotherapy with temozolomide and low-dose interleukin-2 in patients with metastatic melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

29 September 2017

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

29 September 2017

Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

29 September 2017

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

29 September 2017

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

29 September 2017

Telomerase peptide vaccination combined with temozolomide: a clinical trial in stage IV melanoma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

4 September 2018

Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

4 September 2018

Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

4 September 2018

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3698134

4 December 2018

Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/23725550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23725550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cell-based vaccine in advanced melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23725550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/23725550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in Peripheral Blood Level of Regulatory T cells in Patients with Malignant Melanoma During Treatment with Dendritic Cell Vaccination and Low-dose IL-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/23725550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23725550

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1479-5876-11-135

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36972613&oldid=2199664887"